A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Applying to Winship Cancer Institute, Emory University · Atlanta, Georgia
Answer a few short questions to share with the research team.